Viewing nowDiapolmin Tablets 250mg (Metformin Hydrochloride)
Metformin Hydrochloride 250mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 201605146 · Approved 2016.08.26 · Insurance code 694001880
Treatment of type 2 diabetes mellitus
This medication is used for the management of blood glucose levels in patients with type 2 diabetes who have difficulty controlling their blood sugar with diet and exercise alone, especially in overweight adult patients. In adults, it can be used alone or in combination with other oral hypoglycemic agents or insulin. Children aged 10 years and older and adolescents can also use this medication either as monotherapy or in combination with insulin. This medication effectively improves blood glucose control, assisting in the management of diabetes.
The dose should be determined individually based on the patient's response and tolerability, and should not exceed the recommended maximum daily dose. This medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses per day, in the morning and evening. For doses above 2000mg, divide the dose into 3 doses per day and administer with meals; up to a maximum of 2550mg per day may be administered. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the therapeutic response to this medicine and identify the minimum effective dose. Measure blood hemoglobin A1c approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood hemoglobin A1c levels to normal or near-normal levels using the minimum effective dose. In general, if a patient's blood glucose, previously controlled by diet alone, becomes temporarily uncontrolled, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.
Pediatric patients aged 10 years or older or adolescents during growth: The usual starting dose is 500 mg once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 doses.
This medication can cause severe lactic acidosis or hypoglycemia; caution is needed. It should not be administered to patients with moderate to severe renal impairment or those in acute conditions such as dehydration, severe infections, or acute myocardial infarction. It is also contraindicated in patients with acute and unstable heart failure, patients undergoing radiographic procedures with iodinated contrast agents, and those who have hypersensitivity to this medication or other biguanides. It should not be given to patients with type 1 diabetes, diabetic ketoacidosis, or pre-comatose patients. In cases of serious infections, severe traumatic systemic disorders, patients pre- and post-surgery, malnutrition, starvation, or frailty, temporary discontinuation of this medication may be necessary. Patients with hepatic dysfunction, pulmonary embolism, severe pulmonary dysfunction, or excessive alcohol consumption should avoid this medication. When taking this medication, irregular meals, intense exercise, and concurrent medications may increase the risk of lactic acidosis and hypoglycemia; therefore, it should be used with caution. Lactic acidosis is a rare but very serious side effect; if symptoms such as muscle pain, difficulty in breathing, fatigue, or abdominal pain appear, it is essential to consult a physician immediately. Gastrointestinal symptoms such as diarrhea, nausea, and vomiting may commonly occur during early treatment, which can be alleviated by taking it with meals or adjusting the dosage. Hypoglycemia is rare with monotherapy but can occur when used in combination with other hypoglycemic agents or with insufficient food intake, requiring careful monitoring. This medication is excreted through the kidneys, so renal function should be regularly monitored; if renal function declines, the medication dosage should be reduced or stopped. Alcohol can affect the lactate metabolism of this medication, increasing the risk of lactic acidosis, so excessive drinking should be avoided during treatment. During pregnancy, since it crosses the placenta, it should be used cautiously according to the mother's condition, with close monitoring of fetal growth. In breastfeeding mothers, since this medication may be excreted in breast milk, careful consideration should be given to whether to continue breastfeeding or discontinue the medication during treatment. Elderly patients are at higher risk of renal function impairment, so dosage adjustments and regular renal function tests are required. In cases of overdose, the medication can be removed through hemodialysis; therefore, immediate medical attention is needed. This medication may interact with several other medications, so if other medications are being taken, the healthcare provider should be informed. Blood glucose control should be regularly checked, and if abnormal symptoms arise, immediate consultation with healthcare personnel is necessary. This medication does not cause weight gain, making it advantageous for diabetes patients requiring weight management. When administered to children or adolescents, it shows similar efficacy and safety as in adults, but special caution is needed.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is best to maintain a storage temperature between 1°C and 30°C.
White round film-coated tablet
500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 250mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.